Savara (SVRA) Receivables - Other (2010 - 2013)

Savara's (SVRA) quarterly Receivables - Other came in at $29185.0 in Q3 2013, up 186.92% year-on-year from $10172.0 in Q3 2012, and up 202.15% on a QoQ basis from $9659.0 in Q2 2013.

Savara (SVRA) Receivables - Other (2010 - 2013) Analysis & Trends

Savara (SVRA) has 4 years of Receivables - Other data on file, last reported at $29185.0 in Q3 2013.

  • On a quarterly basis, Receivables - Other rose 186.92% year-over-year to $29185.0 in Q3 2013; TTM through Sep 2013 was $29185.0, a 186.92% increase from a year earlier, with the FY2012 full-year figure at $15689.0, down 9.02% from the prior year.
  • Receivables - Other for Q3 2013 stood at $29185.0, up from $9659.0 in the prior quarter.
  • Over the last five years, Receivables - Other for SVRA reached as high as $29185.0 in Q3 2013 and fell as low as $271.0 in Q2 2011.
  • Historically, Receivables - Other has averaged $12580.6 across 4 years, with a median of $10831.0 in 2013.
  • Across the five-year window, Receivables - Other soared 7849.45% in 2012 and slumped 55.16% in 2013, its largest moves.
  • Year by year, Receivables - Other stood at $1980.0 in 2010, then soared by 770.96% to $17245.0 in 2011, then retreated by 9.02% to $15689.0 in 2012, then surged by 86.02% to $29185.0 in 2013.
  • Per Business Quant data, the three most recent Receivables - Other figures were $29185.0 in Q3 2013, $9659.0 in Q2 2013, and $10831.0 in Q1 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Savara 1.24 Bn 1.24 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2013 29,185.00
Sep 30, 2013 29,185.00
Jun 30, 2013 9,659.00
Jun 30, 2013 9,659.00
Mar 31, 2013 10,831.00
Mar 31, 2013 10,831.00
Dec 31, 2012 15,689.00
Dec 31, 2012 15,689.00
Sep 30, 2012 10,172.00
Sep 30, 2012 10,172.00
Jun 30, 2012 21,543.00
Jun 30, 2012 21,543.00
Mar 31, 2012 14,943.00
Mar 31, 2012 14,943.00
Dec 31, 2011 17,245.00
Dec 31, 2011 17,245.00
Sep 30, 2011 6,869.00
Sep 30, 2011 6,869.00
Jun 30, 2011 271.00
Jun 30, 2011 271.00